Andrea Bellisario

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Despite the rapid pace of biomedical innovation, research and development (R&D) productivity in the pharmaceutical industry has not improved broadly. Increasingly, firms need to leverage new approaches to product development and commercial execution, while maintaining adaptability to rapid changes in the marketplace and in biomedical science. Firms are also(More)
  • 1